Home / 会社概要 / ニュース

ニュース

Latest press coverage

All Press Coverage

What’s next for Trump’s ‘most favored nation’ policy?

Rare disease drug development: challenges, support and hopes for the future

FDA to phase out animal testing with AI and lab-based models

Featured press coverage

All Press Coverage

Increasing Productivity In Pharma R&D Starts With Data

This article discusses the growing volume of raw data collected during clinical research, and how transforming the mountain of data into clinical and safety…

注目のプレスリリース

All Press Release

サターラが2025年第1四半期決算を報告

RADNOR, PA— 2025年5月5日-- Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in model-informed drug development, today reported its financial results for the first quarter…

最新プレスリリース一覧

All Press Release

Certara to Participate in Upcoming Investor Conferences

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

Certara Reports Preliminary First Quarter 2025 Financial Results Announces $100 Million Share Repurchase Authorization

Recent Announcements

All Announcement

Certara Enhances Integral Data Repository with Powerful REST API Capabilities in Version 25.4.1

Latest Phoenix PK/PD analysis & modeling platform release prioritizes efficiency, power

Certara Earns Great Place to Work Certification™ for Fourth Consecutive Year

サターラ、第 2 回「Certainty U.S.」イベントの開催を発表

サターラとA2ヘルスケア、日本におけるモデルを活かした医薬品開発（MIDD）の導入を加速

サターラ、バイオウェーバーと戦略的提携を締結、バイオ医薬品分野での能力強化を図る

All news

Increasing Productivity In Pharma R&D Starts With Data

Certara Products - Pinnacle 21, Clinical Trials, Data Standards, Press Coverage

Certara Enhances Integral Data Repository with Powerful REST API Capabilities in Version 25.4.1

Certara Products - Phoenix, Announcement

Latest Phoenix PK/PD analysis & modeling platform release prioritizes efficiency, power

Certara Products, Certara Products - Phoenix, Announcement

Certara Earns Great Place to Work Certification™ for Fourth Consecutive Year

Certara Services, Announcement

What’s next for Trump’s ‘most favored nation’ policy?

Certara Services, Press Coverage

サターラが2025年第1四半期決算を報告

Certara Products, Certara Services, Press Release

Certara to Participate in Upcoming Investor Conferences

プレスリリース

Rare disease drug development: challenges, support and hopes for the future

Certara Services, Press Coverage

サターラ、第 2 回「Certainty U.S.」イベントの開催を発表

Certara Products, Certara Services, Modeling and Simulation, Announcement

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

モデリング＆シミュレーション, プレスリリース

Certara Reports Preliminary First Quarter 2025 Financial Results Announces $100 Million Share Repurchase Authorization

プレスリリース

FDA to phase out animal testing with AI and lab-based models

Certara Products - Simcyp, Certara Services, Press Coverage

1
2
3
…
16
›

MIDDの最新情報をいち早くお届け

医薬品開発の変革はサターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。

© 2025 Certara. All Rights Reserved. | 個人情報保護

Powered by Translations.com GlobalLink Web Software